^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Prolymphocytic Leukemia
    Drug:pentostatin (Adenosine deaminase inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    T-Cell Prolymphocytic Leukemia....Second-line therapy...Preferred regimen: Pentostatin